RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Fuji Pharma Co Stock

Fuji Pharma Co Revenue 2024

Fuji Pharma Co Revenue

47.96 B JPY

Ticker

4554.T

ISIN

JP3816200004

WKN

938283

In 2024, Fuji Pharma Co's sales reached 47.96 B JPY, a 17.29% difference from the 40.89 B JPY sales recorded in the previous year.

The Fuji Pharma Co Revenue history

YEARREVENUE (undefined JPY)GROSS MARGIN (%)
2027e51.4232,12
2026e55.6529,67
2025e51.6631,97
2024e47.9634,44
202340.8940,39
202235.4341,10
202133.9943,40
202033.7944,01
201936.2843,54
201837.9142,07
201735.3941,59
201634.2339,55
201531.6840,94
201429.2242,38
201325.1743,46
201221.5243,09
201121.6247,40
201019.745,86
200917.244,71
200814.9442,70
200713.2544,04
200611.2442,35
200510.1344,27
20049.743,81

Fuji Pharma Co Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Fuji Pharma Co, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Fuji Pharma Co from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Fuji Pharma Co’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Fuji Pharma Co. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Fuji Pharma Co’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Fuji Pharma Co’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Fuji Pharma Co’s growth potential.

Fuji Pharma Co Revenue, EBIT and net profit per share

DateFuji Pharma Co RevenueFuji Pharma Co EBITFuji Pharma Co Net Income
2027e51.42 B undefined0 undefined4.66 B undefined
2026e55.65 B undefined0 undefined4.49 B undefined
2025e51.66 B undefined0 undefined3.99 B undefined
2024e47.96 B undefined0 undefined5.8 B undefined
202340.89 B undefined3.86 B undefined3.44 B undefined
202235.43 B undefined3.78 B undefined2.7 B undefined
202133.99 B undefined3.35 B undefined2.43 B undefined
202033.79 B undefined3.14 B undefined2.09 B undefined
201936.28 B undefined4.17 B undefined2.96 B undefined
201837.91 B undefined4.39 B undefined3.37 B undefined
201735.39 B undefined4.31 B undefined3.3 B undefined
201634.23 B undefined3.57 B undefined2.12 B undefined
201531.68 B undefined3.25 B undefined2.09 B undefined
201429.22 B undefined3.17 B undefined2.08 B undefined
201325.17 B undefined3.26 B undefined2.07 B undefined
201221.52 B undefined2.75 B undefined1.37 B undefined
201121.62 B undefined3.57 B undefined2.21 B undefined
201019.7 B undefined3.23 B undefined1.94 B undefined
200917.2 B undefined2.41 B undefined1.53 B undefined
200814.94 B undefined2.01 B undefined1.25 B undefined
200713.25 B undefined2 B undefined1.19 B undefined
200611.24 B undefined1.47 B undefined916 M undefined
200510.13 B undefined960 M undefined562 M undefined
20049.7 B undefined1.4 B undefined844 M undefined

Fuji Pharma Co stock margins

The Fuji Pharma Co margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Fuji Pharma Co. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Fuji Pharma Co.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Fuji Pharma Co's sales revenue. A higher gross margin percentage indicates that the Fuji Pharma Co retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Fuji Pharma Co's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Fuji Pharma Co's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Fuji Pharma Co's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Fuji Pharma Co. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Fuji Pharma Co's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Fuji Pharma Co Margin History

Fuji Pharma Co Gross marginFuji Pharma Co Profit marginFuji Pharma Co EBIT marginFuji Pharma Co Profit margin
2027e40.39 %0 %9.07 %
2026e40.39 %0 %8.07 %
2025e40.39 %0 %7.73 %
2024e40.39 %0 %12.09 %
202340.39 %9.44 %8.4 %
202241.1 %10.66 %7.61 %
202143.4 %9.85 %7.16 %
202044.01 %9.29 %6.17 %
201943.54 %11.5 %8.16 %
201842.07 %11.58 %8.89 %
201741.59 %12.19 %9.33 %
201639.55 %10.42 %6.19 %
201540.94 %10.26 %6.6 %
201442.38 %10.86 %7.11 %
201343.46 %12.95 %8.21 %
201243.09 %12.76 %6.37 %
201147.4 %16.49 %10.2 %
201045.86 %16.41 %9.87 %
200944.71 %14 %8.87 %
200842.7 %13.45 %8.38 %
200744.04 %15.08 %9.01 %
200642.35 %13.09 %8.15 %
200544.27 %9.48 %5.55 %
200443.81 %14.44 %8.71 %

Fuji Pharma Co Aktienanalyse

What does Fuji Pharma Co do?

Fuji Pharma Co Ltd is a Japanese company specializing in the healthcare industry. The company was founded in 2001 and is headquartered in Tokyo, Japan. It is listed on the Tokyo Stock Exchange and employs over 1,000 employees. Fuji Pharma's business model is to provide its customers with innovative and high-quality products that contribute to improving health and well-being. The company specializes in several business areas, including the development, manufacturing, and marketing of pharmaceutical products, production of OEM products for other companies, and manufacturing of dietary supplements and cosmetics. An important area for Fuji Pharma is the development and production of pharmaceuticals. The company ensures that its medications meet the highest requirements and international standards. This includes research and development of new products. The company has its own research department specializing in the development of medications that can be used in serious diseases such as cancer, diabetes, and cardiovascular diseases. In addition, Fuji Pharma is also involved in the production of OEM products for other companies. The company ensures the manufacture of medications and medical products for other pharmaceutical companies, meeting the highest quality standards and customer requirements. Fuji Pharma is proud to be a trusted partner for its customers and provides its services according to the requirements of its customers. In addition to these two divisions, Fuji Pharma also produces dietary supplements and cosmetics for the domestic and international markets. These products are designed for consumers who want to improve their health and well-being. The company places great emphasis on the development of natural and safe ingredients for its products and ensures the highest standards of quality and safety. Fuji Pharma has also specialized in the Japanese market for medical devices, particularly in the field of home respiratory devices. The company has developed a new generation of respiratory therapy devices that are safe and easy to use, providing better well-being and quality of life for patients with respiratory diseases. In addition to its business areas, Fuji Pharma also has various products in its portfolio that are known for their quality and effectiveness. One such product is "Efil," a medication used in the treatment of erectile dysfunction disorders. The medication is available in Japan and other Asian countries and has already been used by over 200,000 patients. Fuji Pharma continuously strives to improve its research and development activities and develop new innovative products and services for the healthcare industry. The company aims to bring its products and services to the international market and satisfy its customers in Japan and worldwide. Fuji Pharma Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Revenue Details

Understanding Fuji Pharma Co's Sales Figures

The sales figures of Fuji Pharma Co originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing Fuji Pharma Co’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize Fuji Pharma Co's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in Fuji Pharma Co’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about Fuji Pharma Co stock

How much revenue did Fuji Pharma Co generate this year?

Fuji Pharma Co has achieved a revenue of 47.96 B JPY this year.

How much was the turnover of the company Fuji Pharma Co compared to the previous year?

The revenue of Fuji Pharma Co has increased by 17.29% increased compared to the previous year.

What does revenue mean for investors?

The revenue of a company is an important indicator of its financial performance and attractiveness for investors.

Which factors influence the revenue of Fuji Pharma Co?

The revenue of Fuji Pharma Co is influenced by various factors, including the demand for its products and services, market conditions, and prices.

How is the revenue of Fuji Pharma Co measured?

Revenue is typically measured in units referring to the sale of goods and services provided by the company.

How does an increase in sales affect investments?

An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.

What are the possible risks associated with a declining revenue?

A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.

Why is the sales revenue of Fuji Pharma Co so important for investors?

The revenue of Fuji Pharma Co is an important indicator of financial performance and attractiveness for investors.

What strategic measures can a company take to increase revenue?

A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.

How much dividend does Fuji Pharma Co pay?

Over the past 12 months, Fuji Pharma Co paid a dividend of 37 JPY . This corresponds to a dividend yield of about 2.84 %. For the coming 12 months, Fuji Pharma Co is expected to pay a dividend of 38.86 JPY.

What is the dividend yield of Fuji Pharma Co?

The current dividend yield of Fuji Pharma Co is 2.84 %.

When does Fuji Pharma Co pay dividends?

Fuji Pharma Co pays a quarterly dividend. This is distributed in the months of April, October, April, October.

How secure is the dividend of Fuji Pharma Co?

Fuji Pharma Co paid dividends every year for the past 17 years.

What is the dividend of Fuji Pharma Co?

For the upcoming 12 months, dividends amounting to 38.86 JPY are expected. This corresponds to a dividend yield of 2.99 %.

In which sector is Fuji Pharma Co located?

Fuji Pharma Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Fuji Pharma Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Fuji Pharma Co from 12/1/2024 amounting to 22.5 JPY, you needed to have the stock in your portfolio before the ex-date on 9/27/2024.

When did Fuji Pharma Co pay the last dividend?

The last dividend was paid out on 12/1/2024.

What was the dividend of Fuji Pharma Co in the year 2023?

In the year 2023, Fuji Pharma Co distributed 35 JPY as dividends.

In which currency does Fuji Pharma Co pay out the dividend?

The dividends of Fuji Pharma Co are distributed in JPY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Fuji Pharma Co

Our stock analysis for Fuji Pharma Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Fuji Pharma Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.